Jason Tardio

Chief Commercial Officer, Ovid Therapeutics Inc.

Companies

IMMUNIC, INC.Chief operating officer Jul 12, 2024 to now¹
IMMUNIC, INC.President Jul 12, 2024 to now¹
Ovid Therapeutics Inc.Chief operating officer Feb 4, 2022 to Feb 26, 2024²
Ovid Therapeutics Inc.Chief Commercial Officer Nov 21, 2019 to Jul 1, 2021³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

IMMUNIC, INC. IMUX12,512 shares⁴$86.8K at $6.94Jun 5, 2025
Ovid Therapeutics Inc. OVID28,125 shares⁵$61.7K at $2.19Feb 22, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

Jun 5, 2025Bought 12,512 shares at $0.79 of IMMUNIC, INC.⁴
Jun 5, 2025Bought 12,512 shares at $0.79 of IMMUNIC, INC.⁶
Feb 22, 2024Granted 28,125 shares of Ovid Therapeutics Inc.⁵
Sep 12, 2022Sold 17,344 shares at $2.15 of Ovid Therapeutics Inc.⁷

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARIMMUNIC, INC., Chief operating officer
2
SEC EDGAROvid Therapeutics Inc., Chief operating officer
3
SEC EDGAROvid Therapeutics Inc., Chief Commercial Officer
4
SEC EDGARIMMUNIC, INC. shares after the filing of Jun 5, 2025
5
SEC EDGAROvid Therapeutics Inc. shares after the filing of Feb 22, 2024
6
SEC EDGARForm 4 filed Jun 9, 2025
7
SEC EDGARForm 4 filed Sep 14, 2022